Velakast Tablet
Prescription Required
Introduction of Velakast Tablet
Velakast Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.
Velakast Tablet is a combination of two antiviral medicines: Velakast Tablet1 and Velakast Tablet2.
Velakast Tablet is a combination of two antiviral medicines: Velakast Tablet1 and Velakast Tablet2.
Uses of Velakast Tablet
- Treatment of Chronic hepatitis C virus (HCV) infection
Benefits of Velakast Tablet
In Treatment of Chronic hepatitis C virus (HCV) infection
Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). When the infection moves into a long-lasting stage, it is called chronic hepatitis C virus infection. Velakast Tablet helps reduce the number of hepatitis C virus by preventing it from spreading in your body. This helps control the infection and helps you recover faster. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor.
Side effects of Velakast Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Velakast
- Headache
- Tiredness
How to use Velakast Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Velakast Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Velakast Tablet. Please consult your doctor.
Pregnancy
SAFE IF PRESCRIBED
Velakast Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
SAFE IF PRESCRIBED
Velakast Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Velakast Tablet may cause side effects which could affect your ability to drive.
Velakast Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive.
Velakast Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive.
Kidney
CAUTION
Velakast Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Velakast Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Velakast Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Limited information is available on the use of Velakast Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Liver
SAFE IF PRESCRIBED
Velakast Tablet is safe to use in patients with liver disease. No dose adjustment of Velakast Tablet is recommended.
However, inform your doctor if you have any kidney disease as regular monitoring of liver function tests may be advised in some patients while taking this medicine.
However, inform your doctor if you have any kidney disease as regular monitoring of liver function tests may be advised in some patients while taking this medicine.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Velakast Tablet
₹625.0/Tablet
Velpanat Tablet
Natco Pharma Ltd
₹625/tablet
6% costlier
Resof Total 400mg/100mg Tablet
Dr Reddy's Laboratories Ltd
₹625.04/tablet
6% costlier
Hepcvel Tablet
Cipla Ltd
₹625/tablet
6% costlier
Sovihep V Tablet
Zydus Cadila
₹625/tablet
6% costlier
Velasof Tablet
Hetero Drugs Ltd
₹677.17/tablet
15% costlier
Quick tips
Velakast Tablet
- Velakast Tablet is used for the treatment of chronic hepatitis C virus (HCV) infection.
- Take it with food, preferably at the same time everyday.
- You will usually need to take this medicine every day for either 12 or 24 weeks.
- Skipping doses increases the risk of treatment failure. Make sure that you take all your doses at the correct time.
- It may cause fatigue, dizziness, and blurred vision. Don't drive or do anything requiring concentration until you know how it affects you.
- Velakast Tablet may cause headaches. Drink plenty of water and take a suitable painkiller. Inform your doctor if it does not go away.
- Your doctor may monitor your liver function and the amount of hepatitis C virus in your body regularly.
- Do not stop taking this medicine without your doctor’s advice.
Fact Box
Habit Forming
No
Therapeutic Class
ANTI INFECTIVES
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Medscape. Sofosbuvir+Velpatasvir. [Accessed 26 Apr. 2019] (online) Available from:
- Sofosbuvir+Velpatasvir. London, UK: Gilead Sciences Ltd.; 2016 [revised Dec. 2018]. [Accessed 26 Apr. 2019] (online) Available from:
Marketer details
Name: Aprazer Healthcare Pvt Ltd
Address: 36-B, Pusa Rd, Block 11, Old Rajinder Nagar, Rajinder Nagar, New Delhi, Delhi 110060
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹17500
Inclusive of all taxes
28.0 tablets in 1 bottle
SOLD OUT
Notify me